Navigation Links
MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
Date:3/18/2008

- Company Initiates Phase 2a Trial in Patients with Stable Asthma and

Exercise-Induced Bronchoconstriction -

GAITHERSBURG, Md., March 18 /PRNewswire/ -- MedImmune today announced that its clinical program studying an investigational treatment targeting interleukin-9 (IL-9) has advanced with the start of a new trial in patients with asthma. The company initiated a Phase 2a clinical trial designed to assess the potential of its anti-IL-9 monoclonal antibody (MAb), MEDI-528, in patients with stable asthma and exercise-induced bronchoconstriction. This trial is the fourth study of this antibody in patients with asthma.

"Commencing this trial is a promising step in the clinical development of MEDI-528, as preclinical data has suggested that blocking IL-9 may provide clinical benefit for patients with asthma," said Barbara White, vice president, clinical development, inflammatory disease. "We look forward to continuing to work with our network of collaborative researchers to discover and assess novel pathologies and approaches to inflammatory diseases."

The goal of this clinical trial is to assess the safety and tolerability of multiple fixed escalating doses of MEDI-528 in adult patients with stable asthma and exercise-induced bronchoconstriction. The study will also assess the effect of the antibody on exercise challenge testing, as well as the pharmacokinetics and immunogenicity of the investigational treatment. Enrollment of this randomized, double-blind, placebo-controlled trial has commenced at Northeast Medical Research Associates, Inc. and the study is expected to expand to additional sites throughout the United States and Canada. Preliminary safety results from an ongoing Phase 2 trial support the continued development of the antibody in patients with mild-to-moderate asthma.

About Interleukin-9

IL-9 has been associated with symptoms of asthma. It is one of at least 29 naturally occurring interleukins
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
2. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
3. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
4. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
8. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
9. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
10. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
11. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...OWN, N.J., Nov. 5 Osteot...ng field of biologic products for regenerative hea...rd quarter ended September 30, 2009. ,, "During...elease of our three new biologic products MagniFu... and Plexur M® Innovative Grafting," said Sam...
(Date:11/5/2009)...RICHMOND, Calif., Nov. 5 ... a specialty pharmaceutical company focused on the...products that address important therapeutic needs ...ill host a webcast and teleconference with managem...s on Thursday, November 12, 2009, at 5:00 p.m. Eas...
(Date:11/5/2009)... Minn., Nov. 5 ARKRAY, Inc., the w...onitoring systems, today announced that it has rec...dministration for its new GLUCOCARD Vital blood gl...trip platform, which ARKRAY will make available fo...e a significant complement to the existing GLUCOCA...
Breaking Medicine Technology:Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Editor Showcase 3A Health 26 Nutrition Brand to Press Networking Event Scheduled for Aug 17 48215 1Editor Showcase 3A Health 26 Nutrition Brand to Press Networking Event Scheduled for Aug 17 48215 2Editor Showcase 3A Health 26 Nutrition Brand to Press Networking Event Scheduled for Aug 17 48215 3VA Awards 243 7 Million for New Hampshire Veterans Home 48212 1Daytime Nap Has Benefits Beyond Rest for Kids 48210 1
(Date:11/8/2009)...en Medicare, improve coverage for all Americans ,...SUMMARY: Yesterday the United States House of Rep...gislation that would strengthen Medicare for senio...hat prices millions of Americans out of affordable...re for America Act (H.R. 3962) makes prescription ...
(Date:11/8/2009)...ealth holds open house at Victoria campus , ..., 2009 -- UCW Academy of Health invites anyone loo... health care industry to attend their open house i...W Academy of Health, which offers diplomas in area...ces, designs its programs to meet the needs of the...
(Date:11/8/2009)...swire/ -- Tonight the House of Representatives pas...ndmark health reform legislation that will ensure ...stable and secure health care coverage. The legisl...industry,s worst practices, would extend coverage ...4 billion over ten years. Groups representing doct...
(Date:11/8/2009)...th Network (MHN) urges military veterans to learn ...to exposure to chemicals, atomic agents and soot o...ne of those cancers that is two times more prevale...r currently smoke cigarettes. , ...en’s Health Network (MHN) kicked-off their V...
(Date:11/8/2009)...c health advocates committed to achieving meaningf...ov. 7 "Tonight the U.S....he voice of America,s families by passing the Affo... must deliver, without delay, on the promise of me...gado, President and CEO of the National Alliance f...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...ON, April 14 Medical device industry leaders, law...he 2009 Annual Meeting of the Medical Device Manuf...Park Hyatt in Washington, D.C. , , (Logo: h...edical technology companies and healthcare,s most ...
...e 12th annual Boston Stroke Luncheon "Making the S...5th at The Sheraton in Boston from 7:30 a.m. to 12...er forum, a CME/CEU professional symposium, a Powe...lton Resident Margaret Kelly-Hayes, EdD, RN, FAAN,...
...l 14 Intrinsic Therapeutics, Inc. announced today...R) anular prosthesis for use in reconstructing sof...ic approval to distribute the Barricaid throughout... , , "We are very pleased with receiving the CE m...
...r role in treatment, if supply is adequate, study...ws) -- Pancreatic islets, which are hormone-produc... research and could play a major role in future tr...onal Medical Center, in Duarte, Calif., and his co...
...ns April 15 in Partnership with the American Lung ...e 1-800-NO-BUTTS California Smokers, Helpline ...l tax on tobacco in American history taking affect...tion,s www.smokefreesandiego.org website, laun...
...aders Unite to Help Their Communities Adopt a Heal...an one million people already a part of the online...,s 50 Million Pound Challenge, announced today tha... their own communities and in unity with others ac...
Other Medicine News:Health News:AHRQ Director Carolyn Clancy and Dr. Mark McClellan to Address Device Executives 2009 MDMA Annual Meeting 2Health News:Milton resident receives the Helen B. Spaulding Community Conscience Award 2Health News:Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis 2Health News:Pancreatic Islets in Forefront of Diabetes Research 2Health News:BODY WORLDS Exhibition Uses Lung Specimens to Launch Anti-Smoking Campaign at the San Diego Natural History Museum 2Health News:BODY WORLDS Exhibition Uses Lung Specimens to Launch Anti-Smoking Campaign at the San Diego Natural History Museum 3Health News:The 50 Million Pound Challenge Finds Its Stride as Cities Across the Country Hold the First Annual Challenge Walk Off on May 16 2Health News:The 50 Million Pound Challenge Finds Its Stride as Cities Across the Country Hold the First Annual Challenge Walk Off on May 16 3Health News:The 50 Million Pound Challenge Finds Its Stride as Cities Across the Country Hold the First Annual Challenge Walk Off on May 16 4Health News:The 50 Million Pound Challenge Finds Its Stride as Cities Across the Country Hold the First Annual Challenge Walk Off on May 16 5
...c Instruments incorporate a layered design unique ...monitored to prevent stray electrosurgical burns a...ion failure or capacitive coupling; a well-documen...lt into all AEM Instruments provides a neutral ret...
...Laparofan™ single-use laparoscopic fan retra.... It is indicated for endoscopic surgery and may b...aparofan™ single-use J-shaped laparoscopic f... with the Auto Suture™ Laparolift™ arm...
Micro-dissecting Forceps
10mm Anvil Grasper
Medicine Products: